Erectile dysfunction decisions — 2025

The appeal was dismissed for untimely filing, and several claims for service connection were denied due to insufficient evidence linking the claimed conditions to military service or a service-connected disability.

The Board granted service connection for coronary artery disease due to presumed exposure to herbicide agents in service.

The Board denied the veteran's claims for increased ratings and a separate compensable rating for erectile dysfunction associated with diabetes mellitus, as well as for peripheral neuropathy in various extremities.

The Board granted service connection for non-allergic rhinitis on a direct basis prior to August 10, 2022, and for ED as secondary to the Veteran's service-connected prostate cancer. A 30 percent rating was also granted for the cervical spine disability.

The Board remands the claims for further development to obtain an adequate medical opinion regarding the nature and etiology of the Veteran's urge incontinence, erectile dysfunction, and epididymitis.

The Board remands the claim for service connection for erectile dysfunction to obtain a complete medical opinion that addresses all theories of entitlement, including those related to the Veteran's service-connected disabilities and medications.

The Board dismissed the appeal for service connection for obstructive sleep apnea and denied an earlier effective date, a higher rating for anxiety disorder, and service connection for hypertension and erectile dysfunction. The right elbow fracture claim was remanded.

The Board denied earlier effective dates for service connection and ratings, except for TDIU and DEA which were granted as of May 1, 2020.

The Board granted service connection for erectile dysfunction, gastroesophageal reflux disease, a low back condition to include intervertebral disc syndrome, and restless leg syndrome, all found to be secondary to the Veteran's service-connected disabilities.

The Board denied an earlier effective date for service connection for erectile dysfunction and special monthly compensation based on loss of use of a creative organ.

The Board denied service connection for scars of the bilateral hands and arms, denied higher ratings for knee strain, dyspnea, erectile dysfunction, and tinnitus, and remanded several other issues including service connection for headaches disability.

The Board granted an initial rating of 40 percent for degenerative arthritis of the lumbar spine, service connection for prostate cancer and erectile dysfunction, but denied service connection for restless leg syndrome.

The Board remands the claims for service connection for erectile dysfunction and central sleep apnea to correct duty-to-assist errors that occurred prior to the rating decision on appeal.

The Board granted service connection for chronic fatigue syndrome and an acquired psychiatric disorder but denied increased ratings for obstructive sleep apnea, bilateral plantar fasciitis, and erectile dysfunction with hypogonadism.

The Board remands the claims for service connection for obstructive sleep apnea, vertigo, bruxism, and erectile dysfunction as further development is needed.

The Board remands the claims for a total disability rating based on individual unemployability and special monthly compensation due to service-connected disabilities, as additional development is needed.

The Board denied the Veteran's claims for an earlier effective date for service connection for erectile dysfunction and special monthly compensation based on loss of use of a creative organ, as there was no basis to assign an effective date earlier than July 25, 2024.

The Board denied a rating in excess of 70 percent for posttraumatic stress disorder with unspecified depressive disorder and remanded claims for service connection for erectile dysfunction, peripheral neuropathy of the left upper extremity, and peripheral neuropathy of the right lower extremity.

The veteran's appeal for service connection for bilateral feet peripheral neuropathy, erectile dysfunction, hypertension, and prostate cancer was dismissed due to a lack of timely filing.

The appeal for a rating in excess of 20 percent for diabetes mellitus type II with erectile dysfunction and nephropathy was dismissed. The appeals for increased ratings for diabetic peripheral neuropathy, sciatic nerve, left lower extremity and right lower extremity were denied.